Log In Sign Up

CSI EDUCATION

CSI FOCUS D-HF: TELEMEDICINE IN HEART FAILURE

19 February

9:00 AM America/Chicago

2H

Register to Attend

PROGRAM

Overview of telemedicine in heart failure >> William Abraham

Implantable hemodynamic monitors:

Pulmonary artery pressure monitoring using the CardioMEMS-HF System >>
Philip Adamson
Pulmonary artery pressure monitoring using the Cordella System >> Faisal Sharif
Left atrial pressure monitoring using the V-Lap System >> William Abraham
Non-Invasive assessment of lung fluid content:

ReDS >> Stefan Anker
Impedance-based technologies >> tbc
Integrated physiological assessment >> tbc

Heart failure disease management Apps >> Lou Vadlamani

Applying machine learning and artificial intelligence to heart failure telemedicine​ >> Robert Califf

Speakers

William Abraham

A professor of medicine at Ohio State University SOM, Columbus, OH, USA. Features in 4 videos on Wondr Medical. William Abraham generally speaks on PFO/ASD (Closure), Stroke: Persistent Foramen Ovale and PFO closure, 3d Transoesphageal Echo, Pulmonary Hypertension, and Chronic Heart Failure.

Follow

Stefan Anker

A consultant cadiologist at Charite Hospital, Berlin, Germany. Features in 1 video on Wondr Medical. Stefan Anker generally speaks on Cardiology.

Follow

Marat Fudim

A cardiology fellow at Duke University, Durham, NC, USA. Features in 1 video on Wondr Medical. Marat Fudim generally speaks on Acute Heart Failure– Treatment.

Follow

Philip Adamson

Philip Adamson is an interventional cardiologist at University of Otago Christchurch, Christchurch, New Zealand.

Follow

Robert Califf

Robert M. Califf, MD, MACC, is the Head of Clinical Policy and Strategy for Verily and Google Health for Verily and Google Health. Prior to this Dr. Califf was the vice chancellor for health data science for the Duke University School of Medicine; director of Duke Forge, Duke’s center for health data science; and the Donald F. Fortin, MD, Professor of Cardiology. He served as Deputy Commissioner for Medical Products and Tobacco in the U.S. Food and Drug Administration (FDA) from 2015-2016, and as Commissioner of Food and Drugs from 2016-2017. A nationally and internationally recognized leader in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf is a graduate of Duke University School of Medicine. Dr. Califf was the founding director of the Duke Clinical Research Institute and is one of the most frequently cited authors in biomedical science.

Follow

2020 All rights reserved